Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Alber

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Alzheimer'S Disease : JAD|May 4, 2026
Update on the current state of speech and language testing in Alzheimer's diseaseShloka Dhareshwar, Melissa Kane, Courtney Lewis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumSavannah Doster, Ashley N Price, Jordan P Sergio, et al.
Clinical Interventions in Aging|February 19, 2026
The Relationship Between Gait Task Performance and Plasma Biomarkers for Alzheimer's Disease in Cognitively Unimpaired Older Adults and Patients with Mild Cognitive ImpairmentJordan Sergio, Ashley Price, Peter J Snyder, et al.
Investigative Ophthalmology & Visual Science|May 2, 2024
Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's DiseaseSwetha Ravichandran, Peter J Snyder, Jessica Alber, et al.
Alzheimer'S Research & Therapy|October 12, 2023
Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer's diseaseEdmund Arthur, Swetha Ravichandran, Peter J Snyder, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2022
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous ApproachRoos J Jutten, Louisa Thompson, Sietske A M Sikkes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forwardJessica Alber, Danielle Goldfarb, Louisa I Thompson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2020
A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)Jessica Alber, Edmund Arthur, Stuart Sinoff, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 25, 2021
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trialJennifer Ngolab, Michael Donohue, Alison Belsha, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|May 4, 2026
Update on the current state of speech and language testing in Alzheimer's diseaseShloka Dhareshwar, Melissa Kane, Courtney Lewis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumSavannah Doster, Ashley N Price, Jordan P Sergio, et al.
Clinical Interventions in Aging|February 19, 2026
The Relationship Between Gait Task Performance and Plasma Biomarkers for Alzheimer's Disease in Cognitively Unimpaired Older Adults and Patients with Mild Cognitive ImpairmentJordan Sergio, Ashley Price, Peter J Snyder, et al.
Investigative Ophthalmology & Visual Science|May 2, 2024
Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's DiseaseSwetha Ravichandran, Peter J Snyder, Jessica Alber, et al.
Alzheimer'S Research & Therapy|October 12, 2023
Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer's diseaseEdmund Arthur, Swetha Ravichandran, Peter J Snyder, et al.
Alzheimer'S Research & Therapy|March 27, 2020
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay intervalJessica Alber, Paul Maruff, Cláudia Y Santos, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2022
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous ApproachRoos J Jutten, Louisa Thompson, Sietske A M Sikkes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forwardJessica Alber, Danielle Goldfarb, Louisa I Thompson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2020
A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)Jessica Alber, Edmund Arthur, Stuart Sinoff, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 25, 2021
Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trialJennifer Ngolab, Michael Donohue, Alison Belsha, et al.
Pageof 4